Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Please see the latest updates concerning our response to coronavirus.

Lung cancer in non-smokers likely to respond differently to treatment

Lung cancer in non-smokers is a biologically distinct disease from that in smokers, according to a new study. Researchers also found it has characteristics that mean it could be targeted with tailored treatments.
Read more
Kick-start appeal

Our research has temporarily been on hold during the coronavirus crisis, but cancer has not. Many cancer patients are more vulnerable than ever at times like these – and the need to design smarter, kinder and more effective treatments has become even more urgent. We need your support today to help us make up for time lost in defeating cancer.
Support us
Cancer and COVID-19: how coronavirus has delayed vital cancer treatments

Henry French looks at how an Institute of Cancer Research-led study into the impact of the COVID-19 pandemic on people with cancer helped to start a national debate.
Read more
Scientists expand understanding of how DNA is organised

Scientists at The Institute of Cancer Research have uncovered new information about vital structures inside cells which are responsible for organising our DNA.
Read more
‘Reprogramming’ immune cells could switch defence into attack to treat prostate cancer

Drugs that can ‘reprogramme’ immune cells from protecting cancer to attacking it could be an effective new treatment for some men with advanced prostate cancer, a new study shows.
Read more

1/5

Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more